>
Switch to:

Eidos Therapeutics Accounts Payable

: $2.38 Mil (As of Sep. 2020)
View and export this data going back to 2018. Start your Free Trial

Eidos Therapeutics's Accounts Payable for the quarter that ended in Sep. 2020 was $2.38 Mil.

Eidos Therapeutics's quarterly Accounts Payable declined from Mar. 2020 ($3.97 Mil) to Jun. 2020 ($2.24 Mil) but then increased from Jun. 2020 ($2.24 Mil) to Sep. 2020 ($2.38 Mil).

Eidos Therapeutics's annual Accounts Payable increased from Dec. 2017 ($0.57 Mil) to Dec. 2018 ($1.96 Mil) and increased from Dec. 2018 ($1.96 Mil) to Dec. 2019 ($3.15 Mil).


Eidos Therapeutics Accounts Payable Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Eidos Therapeutics Annual Data
Dec16 Dec17 Dec18 Dec19
Accounts Payable 0.09 0.57 1.96 3.15

Eidos Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Accounts Payable Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.57 3.15 3.97 2.24 2.38

Eidos Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Eidos Therapeutics Accounts Payable Related Terms


Eidos Therapeutics Accounts Payable Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)